Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-28T00:30:34.151Z Has data issue: false hasContentIssue false
  • English
  • Français

Environmental Factors Contributing to Antibiotic Resistance

Published online by Cambridge University Press:  02 January 2015

Ian Phillips
Ian Phillips*
Affiliation:
Department of Microbiology, St. Thomas' Hospital, London, England
*
Department of Microbiology, St. Thomas' Hospital and Medical School, London SE1 7EH England
Get access Rights & Permissions [Opens in a new window]

Abstract

The genetic determinants of antibiotic resistance originate as a result of random events, affected only by those physical and chemical agents that stimulate mutation. It is the selection and spread, within and between species, of new genetic material that is influenced by environmental factors, though the intrinsic antibiotic resistance of many opportunistic pathogens remains to be explained.

Depending on the frequency of genetic change, the biochemical resistance mechanism, the efficiency of selection (including access of antibiotic to relevant bacteria), and the opportunity for person-to-person spread, resistance may present in a number of ways. The use of an antibiotic in any individual may give rise to resistance, among pathogens or normal flora, to that antibiotic alone, to some or all members of its class, or to additional unrelated antibacterials, or to the acquisition of new bacteria, from a variety of sources (humans, animals, inanimate environment). A resistant organism may occasionally have other advantages that enable it to spread in the absence of the initial selective agents.

In the absence of controlled experiments, which are difficult or perhaps impossible, the only evidence of the truth of these hypotheses comes from the clinical use of antibiotics. A wise observer will conclude that the emergence of resistance is a rare event in an individual patient, but is commoner but by no means universal in populations, especially those that are closed. He will note the reports of diminished resistance in the presence of increased usage.

The role of academic infection control is to explain all the phenomena observed, and to formulate methods for identifying and countering the actual as opposed to the imagined hazards.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 4 , Issue 6 , December 1983 , pp. 448 - 451
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1983

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Phillips, I: Clinical implications of acquired antimicrobial resistance, Van Furth, R (ed):Evaluation and Management of Hospital infections. New Perspectives in Clinical Microbiology, 5. Martinus Nijhoff, 1982, p 20.CrossRefGoogle Scholar
2.Ridley, M, Barrie, D, Lynn, R, et al: Antibiotic resistant Staphylococcus aureus and hospital antibiotic policies. Lancet 1970; i:230–233.CrossRefGoogle Scholar
3.Phillips, I: Antibiotic policies, in Reeves, D, Geddes, A (eds): Recent Advances on infection. London, Churchill Livingstone, 1979, pp 151–163.Google Scholar
4.Shannon, K, King, A, Phillips, I: Development of resistance to β-lactam antibiotics during therapy of P. aeruginosa infections. Lancet 1981; i:1466.Google Scholar
5.Casewell, MW, Phillips, I: Aspects of the plasmid-mediated antibiotic resistance and epidemiology of Klebsiella species. Am J Med 1981;70:459–462.CrossRefGoogle ScholarPubMed
6.Ridley, M: The current use of antibiotics in the therapeutic use of antibiotics in hospital practice, in Ridley, M, Phillips, I (eds): Edinburgh, Churchill Livingstone, 1966, pp 1–10.Google Scholar
7.Casewell, M, Knight, S: The frequency of in-vivo transfer of antibiotic resistance plasmids amongst gentamicin resistant enterobacteria during endemic infections and colonization, in Periti, P, Grassi, GG (eds): Current Chemotherapy and Immunotherapy. vol 1. Washington, DC, The American Society tor Microbiology. 1981.Google Scholar
8.Knight, S. Casewell, M: Dissemination of resistance plasmids among gentamicin-resistant enterobacteria from hospital patients. Br Med J 1981;283:755–756.CrossRefGoogle ScholarPubMed
9.Phillips, I: Past and current use of clindamycin and lincomycin. J Antimicrob Chemother 1981; (suppl A):11–18.CrossRefGoogle Scholar
10.Threlfall, EJ, Ward, LR. Ashley, AS, et al: Plasmid-encoded trimethoprim resistance in multi-resistant epidemic typhimurium type 204 and 193 in Britain. Br Med J 1980; i:1210–1211.CrossRefGoogle Scholar
11.Lacey, RW: Are resistance bacteria from animals and poultry an important threat to the treatment of human infections? in Jolly, DW, Miller, DSS, Ross, DB, et al (eds): Ten Years on From Swann. London, Association of Veterinarians in Industry, Royal College of Veterinary Surgeons, 1981.Google Scholar